HEALTH CARE SECTOR

 » 

BIOTECHNOLOGY INDUSTRY

 » 

PGNX

progenics pharmaceuticals
(PGNX:NASDAQ GS)

Last $4.17 USD
Change Today -0.14 / -3.25%
Volume 279.7K
PGNX On Other Exchanges
Symbol
Exchange
PGNX:US
NASDAQ GS
PGP:GR
Frankfurt
As of 8:10 PM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).
Financial StatementsRatiosPensions & OptionsSEC Filings

Pension Plan for progenics pharmaceuticals (PGNX)

Shares for Stock Options
-- Million
Common Shares for Exercise
For the fiscal year 2012 in U.S. Dollars
Projected Benefit Obligation--
Accumulative Benefit Obligation--
Total Pension Assets--
Def. Benefit Service Cost--
Def. Benefit Plan Interest Cost--
Def. Benefit Plan Return On Assets--
Def. Benefit Plan Other Cost--
Def. Benefit Plan Total Cost--
Def. Contribution Plan Cost0.54
Total Pension Expense0.54
Exp. Ret. on Pension Assets--
Discount Rate on Obligation--
Assumed Comp. Growth Rate--
Other Post-Retire Benefits Exp.--
Other Benefits Obligation--

Stock Options for progenics pharmaceuticals (PGNX)

Outstanding at Beginning of Year5.60
Issued During the Year0.81
Exercised During the Year0.04
Canceled During the Year1.01
Outstanding at the End of Year5.37
W/Avg. Exercise Price of Options Granted9.54
W/Avg. Exercise Price of Options Outstanding12.27
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $4.17 USD -0.14

PGNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Agenus Inc $4.14 USD -0.11
Cell Therapeutics Inc $1.22 USD +0.06
Dendreon Corp $3.94 USD -0.07
Inovio Pharmaceuticals Inc $0.68 USD +0.006
Sucampo Pharmaceuticals Inc $9.50 USD +0.04
View Industry Companies
 

Industry Analysis

PGNX

Industry Average

Valuation PGNX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.4x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.7x
View Detailed PGNX Financials
 | 
View Sector Analysis

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close